Gender-specific inhibition of platelet aggregation following omega-3 fatty acid supplementation

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 2, 2012, Pages 109-114

  Phang, M ^a,b   Sinclair, A J ^c   Lincz, L F ^d   Garg, M L ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

^d NEWCASTLE MATER HOSPITAL   (Australia)

Author keywords

Docosahexaenoic acid; Eicosapentaenoic acid; Gender; Platelet aggregation; Sex hormones

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID;

ADULT; ARTICLE; AUSTRALIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INTERVENTION STUDY; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEX DIFFERENCE; THROMBOCYTE AGGREGATION;

ADULT; AUSTRALIA; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; INTERVENTION STUDIES; MALE; MIDDLE AGED; PLATELET AGGREGATION; RISK FACTORS; SEX FACTORS;

EID: 84856609821     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2010.04.012     Document Type: Article

References (35)

1. Agirbasli M. Pivotal role of plasminogen-activator inhibitor 1 in vascular disease. Int J Clin Pract 2005 Jan, 59(1):102-106.
2. von Lewinski F., Riggert J., Paulus W. Towards a rationale of platelet aggregation monitoring in stroke prophylaxis?. J Stroke Cerebrovasc Dis 2009 Mar-Apr, 18(2):111-115.
3. Dockrell M.E., Walker B.R., Noon J.P., Watt G.C., Williams B.C., Webb D.J. Platelet aggregation in young men with contrasting predisposition to high blood pressure. Am J Hypertens 1999 Feb, 12(2 Pt 1):115-119.
4. Lazarus S.A., Bowen K., Garg M.L. Tomato juice and platelet aggregation in type 2 diabetes. JAMA 2004 Aug 18, 292(7):805-806.
5. Wang T.H., Bhatt D.L., Topol E.J. Aspirin and clopidogrel resistance: an emerging clinical entity. Eur Heart J 2006 Mar, 27(6):647-654.
6. Grundt H., Nilsen D.W. n-3 fatty acids and cardiovascular disease. Haematologica 2008 Jun, 93(6):807-812.
7. Gaudette D.C., Holub B.J. Albumin-bound docosahexaenoic acid and collagen-induced human platelet reactivity. Lipids 1990 Mar, 25(3):166-169.
8. Nagakawa Y., Orimo H., Harasawa M., Morita I., Yashiro K., Murota S. Effect of eicosapentaenoic acid on the platelet aggregation and composition of fatty acid in man. A double blind study. Atherosclerosis 1983 Apr, 47(1):71-75.
9. Harris W.S., Miller M., Tighe A.P., Davidson M.H., Schaefer E.J. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 2008 Mar, 197(1):12-24.
10. von Schacky C., Fischer S., Weber P.C. Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J Clin Invest 1985 Oct, 76(4):1626-1631.
11. Archer S.L., Green D., Chamberlain M., Dyer A.R., Liu K. Association of dietary fish and n-3 fatty acid intake with hemostatic factors in the coronary artery risk development in young adults (CARDIA) study. Arterioscler Thromb Vasc Biol 1998 Jul, 18(7):1119-1123.
12. Agren J.J., Vaisanen S., Hanninen O., Muller A.D., Hornstra G. Hemostatic factors and platelet aggregation after a fish-enriched diet or fish oil or docosahexaenoic acid supplementation. Prostaglandins Leukot Essent Fatty Acids 1997 Oct, 57(4-5):419-421.
13. Nelson G.J., Schmidt P.S., Bartolini G.L., Kelley D.S., Kyle D. The effect of dietary docosahexaenoic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans. Lipids 1997 Nov, 32(11):1129-1136.
14. Marckmann P., Bladbjerg E.M., Jespersen J. Dietary fish oil (4g daily) and cardiovascular risk markers in healthy men. Arterioscler Thromb Vasc Biol 1997 Dec, 17(12):3384-3391.
15. Phang M., Garg M.L., Sinclair A.J. Inhibition of platelet aggregation by omega-3 polyunsaturated fatty acids is gender specific-Redefining platelet response to fish oils. Prostaglandins Leukot Essent Fatty Acids 2009 Jul, 81(1):35-40.
16. Cardinal D.C., Flower R.J. The electronic aggregrometer: a novel device for assessing platelet behaviour in blood. J Pharmacol Methods 1980, 3:135-158.
17. Conquer J.A., Holub B.J. Supplementation with an algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects. J Nutr 1996 Dec, 126(12):3032-3039.
18. Vidgren H.M., Agren J.J., Schwab U., Rissanen T., Hanninen O., Uusitupa M.I. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men. Lipids 1997 Jul, 32(7):697-705.
19. Cheryk L.A., Conquer J.A., Holub B.J., Gentry P.A. Docosahexaenoic acid and docosapentanoic acid incorporation into human platelets after 24 and 72 hours: inhibitory effects on platelet reactivity. Platelets 1999 Jul, 10(4):203-211.
20. von Schacky C., Weber P.C. Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. J Clin Invest 1985 Dec, 76(6):2446-2450.
21. Seo J., Barhoumi R., Johnson A.E., Lupton J.R., Chapkin R.S. Docosahexaenoic acid selectively inhibits plasma membrane targeting of lipidated proteins. FASEB J 2006 Apr, 20(6):770-772.
22. Das U.N. Estrogen, statins, and polyunsaturated fatty acids: similarities in their actions and benefits-is there a common link?. Nutrition 2002 Feb, 18(2):178-188. (Burbank, Los Angeles County, Calif).
23. Bayon Y., Croset M., Daveloose D., Guerbette F., Chirouze V., Viret J., et al. Effect of specific phospholipid molecular species incorporated in human platelet membranes on thromboxane A2/prostaglandin H2 receptors. J Lipid Res 1995 Jan, 36(1):47-56.
24. Matsuda K., Mathur R.S., Duzic E., Halushka P.V. Androgen regulation of thromboxane A2/prostaglandin H2 receptor expression in human erythroleukemia cells. Am J Physiol 1993 Dec, 265(6 Pt 1):E928-E934.
25. Matsuda K., Ruff A., Morinelli T.A., Mathur R.S., Halushka P.V. Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and platelets. Am J Physiol 1994 Sep, 267(3 Pt 2):H887-H893.
26. Ajayi A.A., Mathur R., Halushka P.V. Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses. Circulation 1995 Jun 1, 91(11):2742-2747.
27. De Caterina R., Spiecker M., Solaini G., Basta G., Bosetti F., Libby P., et al. The inhibition of endothelial activation by unsaturated fatty acids. Lipids 1999, 34(Suppl.):S191-S194.
28. Eschen O., Christensen J.H., De Caterina R., Schmidt E.B. Soluble adhesion molecules in healthy subjects: a dose-response study using n-3 fatty acids. Nutr Metab Cardiovasc Dis 2004 Aug, 14(4):180-185.
29. Caulin-Glaser T., Watson C.A., Pardi R., Bender J.R. Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest 1996 Jul 1, 98(1):36-42.
30. Ponthieux A., Herbeth B., Droesch S., Lambert D., Visvikis S. Age- and sex-related reference values for serum adhesion molecule concentrations in healthy individuals: intercellular adhesion molecule-1 and E-, P-, and L-selectin. Clin Chem 2003 Sep, 49(9):1544-1546.
31. Pawlosky R., Hibbeln J., Lin Y., Salem N. n-3 fatty acid metabolism in women. Br J Nutr 2003 Nov, 90(5):993-994. [discussion 4-5].
32. Thorngren M., Gustafson A. Effects of 11-week increases in dietary eicosapentaenoic acid on bleeding time, lipids, and platelet aggregation. Lancet 1981 Nov 28, 2(8257):1190-1193.
33. Thaulow E., Erikssen J., Sandvik L., Stormorken H., Cohn P.F. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 1991 Aug, 84(2):613-617.
34. Burdge G.C., Calder P.C. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev 2005 Sep-Oct, 45(5):581-597.
35. Woodman R.J., Mori T.A., Burke V., Puddey I.B., Barden A., Watts G.F., et al. Effects of purified eicosapentaenoic acid and docosahexenoic acid on platelet, fibrinolytic and vascular function in hypersensitive type 2 diabetic patients. Antherosclerosis 2003, 166(1):85-93.